Cannabis Sativa, Inc. Logo

Cannabis Sativa, Inc.

CBDS

(1.2)
Stock Price

0,01 USD

-678.42% ROA

159.88% ROE

-1.01x PER

Market Cap.

1.286.628,00 USD

-58.71% DER

0% Yield

-115.35% NPM

Cannabis Sativa, Inc. Stock Analysis

Cannabis Sativa, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Cannabis Sativa, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (-0.44x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (-119%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

4 ROE

Negative ROE (-943.44%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (-1329.48%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Cannabis Sativa, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Cannabis Sativa, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Sell
4 Stoch RSI Sell

Cannabis Sativa, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Cannabis Sativa, Inc. Revenue
Year Revenue Growth
2007 220.000
2008 226.631 2.93%
2009 182.160 -24.41%
2010 172.771 -5.43%
2011 183.337 5.76%
2012 152.375 -20.32%
2013 1.084 -13956.73%
2014 7.151 84.84%
2015 11.610 38.41%
2016 29.168 60.2%
2017 317.985 90.83%
2018 505.705 37.12%
2019 1.159.737 56.39%
2020 2.035.283 43.02%
2021 1.841.558 -10.52%
2022 1.558.752 -18.14%
2023 1.084.828 -43.69%
2023 1.173.830 7.58%
2024 937.564 -25.2%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Cannabis Sativa, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 3.712 100%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Cannabis Sativa, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 150.000
2008 160.860 6.75%
2009 174.460 7.8%
2010 169.932 -2.66%
2011 0 0%
2012 177.004 100%
2013 246.957 28.33%
2014 1.323.415 81.34%
2015 7.303.371 81.88%
2016 2.821.657 -158.83%
2017 7.029.678 59.86%
2018 4.163.005 -68.86%
2019 2.367.996 -75.8%
2020 2.965.248 20.14%
2021 2.371.736 -25.02%
2022 2.075.373 -14.28%
2023 1.402.532 -47.97%
2023 1.463.838 4.19%
2024 1.367.520 -7.04%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Cannabis Sativa, Inc. EBITDA
Year EBITDA Growth
2007 30.000
2008 36.137 16.98%
2009 -11.489 414.54%
2010 -13.970 17.76%
2011 4.757 393.67%
2012 -36.853 112.91%
2013 -245.880 85.01%
2014 -1.243.520 80.23%
2015 -7.193.934 82.71%
2016 -2.457.878 -192.69%
2017 -6.268.536 60.79%
2018 -3.304.715 -89.68%
2019 -1.867.078 -77%
2020 -2.309.564 19.16%
2021 -1.557.509 -48.29%
2022 -1.152.934 -35.09%
2023 -174.260 -561.62%
2023 -703.890 75.24%
2024 -790.560 10.96%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Cannabis Sativa, Inc. Gross Profit
Year Gross Profit Growth
2007 170.000
2008 174.536 2.6%
2009 140.350 -24.36%
2010 132.142 -6.21%
2011 147.073 10.15%
2012 137.989 -6.58%
2013 -75 184085.33%
2014 4.726 101.59%
2015 5.823 18.84%
2016 1.847 -215.27%
2017 163.534 98.87%
2018 295.834 44.72%
2019 696.797 57.54%
2020 1.141.801 38.97%
2021 1.142.180 0.03%
2022 960.910 -18.86%
2023 674.940 -42.37%
2023 6.391 -10460.79%
2024 211.912 96.98%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Cannabis Sativa, Inc. Net Profit
Year Net Profit Growth
2007 10.000
2008 2.596 -285.21%
2009 -38.192 106.8%
2010 -41.544 8.07%
2011 -15.817 -162.65%
2012 -44.109 64.14%
2013 -43.350.914 99.9%
2014 -14.369.732 -201.68%
2015 -7.432.859 -93.33%
2016 -3.133.376 -137.22%
2017 -7.564.084 58.58%
2018 -4.128.346 -83.22%
2019 -3.985.994 -3.57%
2020 -2.233.548 -78.46%
2021 -2.514.501 11.17%
2022 -955.783 -163.08%
2023 -910.992 -4.92%
2023 -1.392.223 34.57%
2024 -1.503.320 7.39%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Cannabis Sativa, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 -3 100%
2014 -1 -200%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Cannabis Sativa, Inc. Free Cashflow
Year Free Cashflow Growth
2007 50.000
2008 10.776 -363.99%
2009 -17.350 162.11%
2010 -14.293 -21.39%
2011 -897 -1493.42%
2012 -22.818 96.07%
2013 -334.271 93.17%
2014 -430.106 22.28%
2015 -286.874 -49.93%
2016 -252.018 -13.83%
2017 -1.124.259 77.58%
2018 -690.506 -62.82%
2019 92.279 848.28%
2020 -250.300 136.87%
2021 -245.986 -1.75%
2022 -237.149 -3.73%
2023 19.897 1291.88%
2023 -63.111 131.53%
2024 -212.555 70.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Cannabis Sativa, Inc. Operating Cashflow
Year Operating Cashflow Growth
2007 50.000
2008 12.876 -288.32%
2009 -16.465 178.2%
2010 -14.293 -15.2%
2011 78 18424.36%
2012 -22.010 100.35%
2013 -325.364 93.24%
2014 -408.481 20.35%
2015 -278.464 -46.69%
2016 -252.018 -10.49%
2017 -964.661 73.87%
2018 -689.876 -39.83%
2019 94.648 828.89%
2020 -191.756 149.36%
2021 -245.986 22.05%
2022 -235.559 -4.43%
2023 19.897 1283.89%
2023 -63.111 131.53%
2024 -212.555 70.31%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Cannabis Sativa, Inc. Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 2.100 100%
2009 885 -137.29%
2010 0 0%
2011 975 100%
2012 808 -20.67%
2013 8.907 90.93%
2014 21.625 58.81%
2015 8.410 -157.13%
2016 0 0%
2017 159.598 100%
2018 630 -25233.02%
2019 2.369 73.41%
2020 58.544 95.95%
2021 0 0%
2022 1.590 100%
2023 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Cannabis Sativa, Inc. Equity
Year Equity Growth
2007 50.000
2008 49.022 -2%
2009 10.830 -352.65%
2010 -30.714 135.26%
2011 -46.531 33.99%
2012 -77.890 40.26%
2013 -32.504.525 99.76%
2014 -279.615 -11524.74%
2015 2.878.711 109.71%
2016 2.832.908 -1.62%
2017 6.213.798 54.41%
2018 3.303.828 -88.08%
2019 1.160.754 -184.63%
2020 1.638.215 29.15%
2021 1.044.900 -56.78%
2022 1.672.682 37.53%
2023 757.391 -120.85%
2023 1.025.687 26.16%
2024 296.480 -245.95%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Cannabis Sativa, Inc. Assets
Year Assets Growth
2007 140.000
2008 80.837 -73.19%
2009 60.241 -34.19%
2010 27.035 -122.83%
2011 19.494 -38.68%
2012 9.171 -112.56%
2013 27.312 66.42%
2014 3.681.080 99.26%
2015 3.250.533 -13.25%
2016 3.710.775 12.4%
2017 7.712.647 51.89%
2018 4.872.677 -58.28%
2019 2.981.517 -63.43%
2020 3.214.116 7.24%
2021 2.562.582 -25.42%
2022 2.570.791 0.32%
2023 2.020.554 -27.23%
2023 2.122.539 4.8%
2024 1.944.526 -9.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Cannabis Sativa, Inc. Liabilities
Year Liabilities Growth
2007 100.000
2008 31.815 -214.32%
2009 49.411 35.61%
2010 57.749 14.44%
2011 66.025 12.53%
2012 87.061 24.16%
2013 32.531.837 99.73%
2014 3.960.695 -721.37%
2015 371.822 -965.21%
2016 877.867 57.64%
2017 1.498.849 41.43%
2018 1.568.849 4.46%
2019 1.820.763 13.84%
2020 1.575.901 -15.54%
2021 1.517.682 -3.84%
2022 898.109 -68.99%
2023 1.263.163 28.9%
2023 1.096.852 -15.16%
2024 1.648.046 33.45%

Cannabis Sativa, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.01
Net Income per Share
-0.01
Price to Earning Ratio
-1.01x
Price To Sales Ratio
1.33x
POCF Ratio
-4.52
PFCF Ratio
-5.18
Price to Book Ratio
-1.09
EV to Sales
1.89
EV Over EBITDA
-3.08
EV to Operating CashFlow
-7.35
EV to FreeCashFlow
-7.35
Earnings Yield
-0.99
FreeCashFlow Yield
-0.19
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.05
Graham NetNet
-0.02

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.23
ROE
1.6
Return On Assets
-0.57
Return On Capital Employed
-0.69
Net Income per EBT
0.99
EBT Per Ebit
1.38
Ebit per Revenue
-0.84
Effective Tax Rate
0.01

Margins

Sales, General, & Administrative to Revenue
1.37
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0.18
Gross Profit Margin
0.22
Operating Profit Margin
-0.84
Pretax Profit Margin
-1.16
Net Profit Margin
-1.15

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
1.9
Return on Tangible Assets
-6.78
Days Sales Outstanding
0
Days Payables Outstanding
68.51
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
5.33
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0.02
Shareholders Equity per Share
-0.01
Interest Debt per Share
0.01
Debt to Equity
-0.59
Debt to Assets
0.31
Net Debt to EBITDA
-0.91
Current Ratio
0.11
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
1104818
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.92
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.47

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Cannabis Sativa, Inc. Dividends
Year Dividends Growth

Cannabis Sativa, Inc. Profile

About Cannabis Sativa, Inc.

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

CEO
Mr. David M. Tobias
Employee
7
Address
450 Hillside Drive
Mesquite, 89027

Cannabis Sativa, Inc. Executives & BODs

Cannabis Sativa, Inc. Executives & BODs
# Name Age
1 Ms. Catherine J. Carroll
Treasurer & Director
70
2 Ms. Carolyn Merrill
Controller
70
3 Mr. David M. Tobias
Chief Executive Officer, Chief Financial Officer, President, Secretary & Director
70

Cannabis Sativa, Inc. Competitors